SI2346833T1 - Postopek brez diazonija za pripravo indazolnega intermediata v sintezi bicikliäśnih amidov 5-(trifluorometoksi)-1h-3-indazolkarboksilne kisline - Google Patents

Postopek brez diazonija za pripravo indazolnega intermediata v sintezi bicikliäśnih amidov 5-(trifluorometoksi)-1h-3-indazolkarboksilne kisline

Info

Publication number
SI2346833T1
SI2346833T1 SI200930588T SI200930588T SI2346833T1 SI 2346833 T1 SI2346833 T1 SI 2346833T1 SI 200930588 T SI200930588 T SI 200930588T SI 200930588 T SI200930588 T SI 200930588T SI 2346833 T1 SI2346833 T1 SI 2346833T1
Authority
SI
Slovenia
Prior art keywords
trifluormethoxy
diazonium
bicyclic
synthesis
make
Prior art date
Application number
SI200930588T
Other languages
English (en)
Inventor
Thomas P. Cleary
Yaohui Ji
Thimma Rawalpally
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of SI2346833T1 publication Critical patent/SI2346833T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200930588T 2008-10-13 2009-10-06 Postopek brez diazonija za pripravo indazolnega intermediata v sintezi bicikliäśnih amidov 5-(trifluorometoksi)-1h-3-indazolkarboksilne kisline SI2346833T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10477708P 2008-10-13 2008-10-13
PCT/EP2009/062952 WO2010043515A1 (en) 2008-10-13 2009-10-06 Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides
EP09783778A EP2346833B1 (en) 2008-10-13 2009-10-06 Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides

Publications (1)

Publication Number Publication Date
SI2346833T1 true SI2346833T1 (sl) 2013-06-28

Family

ID=41508367

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930588T SI2346833T1 (sl) 2008-10-13 2009-10-06 Postopek brez diazonija za pripravo indazolnega intermediata v sintezi bicikliäśnih amidov 5-(trifluorometoksi)-1h-3-indazolkarboksilne kisline

Country Status (14)

Country Link
US (2) US8232412B2 (sl)
EP (1) EP2346833B1 (sl)
JP (1) JP5425915B2 (sl)
KR (1) KR101338726B1 (sl)
CN (1) CN102186826B (sl)
BR (1) BRPI0920187A2 (sl)
CA (1) CA2740311C (sl)
DK (1) DK2346833T3 (sl)
ES (1) ES2407647T3 (sl)
IL (1) IL211931A (sl)
MX (1) MX2011003429A (sl)
PL (1) PL2346833T3 (sl)
SI (1) SI2346833T1 (sl)
WO (1) WO2010043515A1 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2933398B1 (fr) 2008-07-04 2011-02-18 Saint Gobain Ct Recherches Grains fondus d'oxydes comprenant al, ti et mg et produits ceramiques comportant de tels grains
JO3250B1 (ar) 2009-09-22 2018-09-16 Novartis Ag إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
MX2013008704A (es) 2011-01-27 2013-08-21 Novartis Ag Uso de activadores del receptor de acetil-colina nicotinico alfa-7.
AU2012232711B2 (en) 2011-03-18 2016-04-28 Novartis Ag Combinations of alpha 7 nicotinic acetylcholine receptor activators and mGluR5 antagonists for use in dopamine induced dyskinesia in Parkinson's Disease
CN103930112B (zh) 2011-10-20 2018-11-09 诺华股份有限公司 预测对α7烟碱型乙酰胆碱受体激活剂疗法的响应的生物标志物
CN102837985A (zh) * 2012-09-21 2012-12-26 广州广电运通金融电子股份有限公司 金融自助设备及其薄片介质传输系统和传输方法
ES2661050T3 (es) 2012-12-11 2018-03-27 Novartis Ag Biomarcador predictivo de la capacidad de respuesta a tratamiento con activador del receptor nicotínico de acetilcolina alfa-7
CA2898045C (en) 2013-01-15 2018-08-28 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists
CN105263495B (zh) 2013-01-15 2019-05-14 诺华有限公司 α7烟碱型乙酰胆碱受体激动剂的应用
WO2014111751A1 (en) 2013-01-15 2014-07-24 Novartis Ag Use of alpha 7 nicotinic receptor agonists for the treatment of narcolepsy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4824578B2 (ja) * 2003-12-22 2011-11-30 メモリー・ファーマシューティカルズ・コーポレイション インドール類、1,2−ベンズイソオキサゾール類、および1,2−ベンゾイソチアゾール類、ならびにそれらの製造と使用
BRPI0508771A (pt) 2004-03-25 2007-08-14 Memory Pharm Corp indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
ATE487716T1 (de) 2004-04-22 2010-11-15 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzisoxazole, 1,2- benzoisothiazole, deren herstellung und verwendungen
US7632831B2 (en) 2004-05-07 2009-12-15 Memory Pharmaceuticals Corporation 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
DE102004054666A1 (de) 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
US20060142247A1 (en) 2004-12-17 2006-06-29 Guy Georges Tricyclic heterocycles
AU2005319248A1 (en) * 2004-12-22 2006-06-29 Memory Pharmaceuticals Corporation Nicotinic alpha-7 receptor ligands and preparation and uses thereof
AU2006295397A1 (en) * 2005-09-23 2007-04-05 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof

Also Published As

Publication number Publication date
BRPI0920187A2 (pt) 2019-08-27
CN102186826A (zh) 2011-09-14
JP2012505175A (ja) 2012-03-01
AU2009304171A1 (en) 2010-04-22
US20100094011A1 (en) 2010-04-15
IL211931A (en) 2016-07-31
IL211931A0 (en) 2011-06-30
EP2346833B1 (en) 2013-03-27
DK2346833T3 (da) 2013-04-29
KR101338726B1 (ko) 2013-12-06
EP2346833A1 (en) 2011-07-27
WO2010043515A1 (en) 2010-04-22
PL2346833T3 (pl) 2013-08-30
US8354536B2 (en) 2013-01-15
MX2011003429A (es) 2011-05-02
CA2740311A1 (en) 2010-04-22
ES2407647T3 (es) 2013-06-13
JP5425915B2 (ja) 2014-02-26
CN102186826B (zh) 2015-06-17
KR20110067063A (ko) 2011-06-20
US20120259120A1 (en) 2012-10-11
US8232412B2 (en) 2012-07-31
CA2740311C (en) 2013-09-17

Similar Documents

Publication Publication Date Title
IL211931A0 (en) Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides
IL207151A0 (en) Method for the regioselective synthesis of 1-alkyl-3-haloalkyl-pyrazole-4 carboxylic acid derivatives
IL202229A0 (en) Pyrazole carboxylic acid amides useful as microbiocides
IL207487A0 (en) Process for the regioselective synthesis of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
SI2178840T1 (sl) Derivativi azabifenilaminobenzojske kisline kot dhodh inhibitorji
PL2121577T3 (pl) Sposób syntezy kwasów omega-aminoalkanowych
ZA201002471B (en) Amides useful as inhibitors of voltage-gated sodium channels
EP2254944A4 (en) COMPOSITION FOR THE FORMATION OF GELS
ZA201100528B (en) Method for the synthesis of bioresourced acrylic acid esters
EP2299824A4 (en) Pyrazoline Derivatives as FAAH Inhibitors
AP2009004935A0 (en) New process for the synthesis of agomelatine
IL207049A0 (en) Synthesis of resorcylic acid lactones useful as therapeutic agents
IL213344A0 (en) Methods for the preparation of aryl amides
ZA200905335B (en) Process for the synthesis of agomelatine
IL208792A0 (en) Process for the preparation of amides
HK1168588A1 (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)- cyclopropanecarboxylic acid 1-(2--4-)-
PL2279175T3 (pl) Sposób wytwarzania związków pośrednich naftalen-2-ylopirazol-3-onu użytecznych w syntezie inhibitorów receptorów sigma
IL208597A0 (en) Anhydrous crystal form of orvepitant maleate
IL219274A0 (en) Process for synthesis of intermediates useful for making substituted indazole and azindazole compounds
EG26957A (en) Process for the preparation of pyrazole carboxylicacid amides
ZA200905051B (en) Process for the synthesis of agomelatine
IL213144A (en) Processes for the preparation of 5-formyl-pyridine-3,2-dicarboxylic acid esters and their derivatives and their uses for the preparation of herbicides
IL208868A0 (en) Processes for the preparation of amides
EP2132171A4 (en) NOVEL CRYSTALLINE FORMS OF PYRROLYLHEPTANOIC ACID DERIVATIVES
PL2240442T3 (pl) Sposób wytwarzania przydatny w syntezie atorwastatyny